Effectiveness comparisons of Chinese patent medicine on insomnia: A protocol for systematic review and Bayesian network meta-analysis.
Medicine (Baltimore)
; 100(5): e24446, 2021 Feb 05.
Article
in En
| MEDLINE
| ID: mdl-33592893
ABSTRACT
BACKGROUND:
In recent years, the incidence of insomnia is increasing. However, the existing therapy methods for cannot fundamentally treat the disease. Meanwhile, Chinese patent medicine (CPM) plays an active role in the treatment of insomnia. However, there is no comparison and ranking of the efficacy of every CPM. Therefore, our study will use network meta-analysis to compare the efficacy of different CPM on insomnia, in order to provide evidence-based medical evidence for clinical treatment.METHODS:
We will search CNKI, Wanfang, VIP, CBM, Pubmed, Cochrane Library, Embase for the randomized controlled trials of CPM in the treatment of insomnia (up to December 31, 2020). We will use RevMan5.3, Stata15.1 and ADDIS software for statistical analysis. We will draw the surface under cumulative ranking area to predict the order of efficacy.RESULTS:
We aim to rank the efficacy and safety of different CPM for the treatment of insomnia.CONCLUSION:
CPM plays a positive role in the treatment of insomnia and can provide evidence support for clinicians and patients. INPLASY REGISTRATION NUMBER INPLASY2020120121.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Chinese Herbal
/
Nonprescription Drugs
/
Sleep Initiation and Maintenance Disorders
/
Medicine, Chinese Traditional
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Systematic_reviews
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Medicine (Baltimore)
Year:
2021
Document type:
Article